{
  "item1": "RSV patent portfolio includes multiple families differing patent breadth . non-exhaustive list granted patents covering RSV vaccine can found following table. Composition Matter Composition Matter Composition Matter Composition Matter Method Use Composition Matter Composition Matter Composition Matter Composition Matter Composition Matter Composition Matter Composition Matter Method Use Composition Matter * Selected granted patents U.S. Europe only.",
  "item7": "Other revenue comprises grant revenue, collaboration revenue, licensing royalty revenue. Grant collaboration revenues been primarily derived government-sponsored private organizations including Biomedical Advanced Research Development Authority (BARDA), Defense Advanced Research Projects Agency (DARPA) Gates Foundation strategic alliances Merck & Co., Inc (Merck), Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals (Europe) Limited (together, Vertex) others discover, develop, commercialize potential mRNA medicines. Licensing royalty revenue related out-licensing agreement mRNA COVID related intellectual property Japan, executed 2024. following table summarizes other revenue periods presented (in millions): Years Ended December 31, Collaboration revenue Licensing royalty revenue Cost sales includes raw materials, personnel facility other costs associated manufacturing commercial products.",
  "item2": null
}